Pfizer Bolsters Obesity Pipeline with $4.9 Billion Metsera Acquisition; Bristol Myers Squibb Aligns Global Schizophrenia Drug Pricing
Key Takeaways Pfizer (PFE) is set to acquire Metsera for an enterprise value of approximately $4.9 billion, significantly expanding its […]
